» Articles » PMID: 20537162

A Novel Chemogenomics Analysis of G Protein-coupled Receptors (GPCRs) and Their Ligands: a Potential Strategy for Receptor De-orphanization

Overview
Publisher Biomed Central
Specialty Biology
Date 2010 Jun 12
PMID 20537162
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: G protein-coupled receptors (GPCRs) represent a family of well-characterized drug targets with significant therapeutic value. Phylogenetic classifications may help to understand the characteristics of individual GPCRs and their subtypes. Previous phylogenetic classifications were all based on the sequences of receptors, adding only minor information about the ligand binding properties of the receptors. In this work, we compare a sequence-based classification of receptors to a ligand-based classification of the same group of receptors, and evaluate the potential to use sequence relatedness as a predictor for ligand interactions thus aiding the quest for ligands of orphan receptors.

Results: We present a classification of GPCRs that is purely based on their ligands, complementing sequence-based phylogenetic classifications of these receptors. Targets were hierarchically classified into phylogenetic trees, for both sequence space and ligand (substructure) space. The overall organization of the sequence-based tree and substructure-based tree was similar; in particular, the adenosine receptors cluster together as well as most peptide receptor subtypes (e.g. opioid, somatostatin) and adrenoceptor subtypes. In ligand space, the prostanoid and cannabinoid receptors are more distant from the other targets, whereas the tachykinin receptors, the oxytocin receptor, and serotonin receptors are closer to the other targets, which is indicative for ligand promiscuity. In 93% of the receptors studied, de-orphanization of a simulated orphan receptor using the ligands of related receptors performed better than random (AUC > 0.5) and for 35% of receptors de-orphanization performance was good (AUC > 0.7).

Conclusions: We constructed a phylogenetic classification of GPCRs that is solely based on the ligands of these receptors. The similarities and differences with traditional sequence-based classifications were investigated: our ligand-based classification uncovers relationships among GPCRs that are not apparent from the sequence-based classification. This will shed light on potential cross-reactivity of GPCR ligands and will aid the design of new ligands with the desired activity profiles. In addition, we linked the ligand-based classification with a ligand-focused sequence-based classification described in literature and proved the potential of this method for de-orphanization of GPCRs.

Citing Articles

Co-Evolution of Opioid and Adrenergic Ligands and Receptors: Shared, Complementary Modules Explain Evolution of Functional Interactions and Suggest Novel Engineering Possibilities.

Root-Bernstein R, Churchill B Life (Basel). 2021; 11(11).

PMID: 34833093 PMC: 8623292. DOI: 10.3390/life11111217.


An Integrated Approach toward NanoBRET Tracers for Analysis of GPCR Ligand Engagement.

Killoran M, Levin S, Boursier M, Zimmerman K, Hurst R, Hall M Molecules. 2021; 26(10).

PMID: 34065854 PMC: 8151276. DOI: 10.3390/molecules26102857.


Chemogenetic Approach Using Ni(II) Complex-Agonist Conjugates Allows Selective Activation of Class A G-Protein-Coupled Receptors.

Kubota R, Nomura W, Iwasaka T, Ojima K, Kiyonaka S, Hamachi I ACS Cent Sci. 2018; 4(9):1211-1221.

PMID: 30276255 PMC: 6161059. DOI: 10.1021/acscentsci.8b00390.


Orphan receptor ligand discovery by pickpocketing pharmacological neighbors.

Ngo T, Ilatovskiy A, Stewart A, Coleman J, McRobb F, Riek R Nat Chem Biol. 2016; 13(2):235-242.

PMID: 27992882 PMC: 5247308. DOI: 10.1038/nchembio.2266.


CFam: a chemical families database based on iterative selection of functional seeds and seed-directed compound clustering.

Zhang C, Tao L, Qin C, Zhang P, Chen S, Zeng X Nucleic Acids Res. 2014; 43(Database issue):D558-65.

PMID: 25414339 PMC: 4383987. DOI: 10.1093/nar/gku1212.


References
1.
Bondensgaard K, Ankersen M, Thogersen H, Hansen B, Wulff B, Bywater R . Recognition of privileged structures by G-protein coupled receptors. J Med Chem. 2004; 47(4):888-99. DOI: 10.1021/jm0309452. View

2.
Klabunde T . Chemogenomic approaches to drug discovery: similar receptors bind similar ligands. Br J Pharmacol. 2007; 152(1):5-7. PMC: 1978276. DOI: 10.1038/sj.bjp.0707308. View

3.
Abramovitz M, Adam M, Boie Y, Carriere M, Denis D, Godbout C . The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim Biophys Acta. 2000; 1483(2):285-93. DOI: 10.1016/s1388-1981(99)00164-x. View

4.
Tamura K, Dudley J, Nei M, Kumar S . MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol. 2007; 24(8):1596-9. DOI: 10.1093/molbev/msm092. View

5.
Fredriksson R, Lagerstrom M, Lundin L, Schioth H . The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol. 2003; 63(6):1256-72. DOI: 10.1124/mol.63.6.1256. View